327 related articles for article (PubMed ID: 35510161)
1. Genetic Diversity and in vitro Activity of Aztreonam/Avibactam and Ceftazidime/Avibactam Against Carbapenem-Resistant
Sun S; Chen K; Kong X; Tian W; Niu S
Infect Drug Resist; 2022; 15():2243-2251. PubMed ID: 35510161
[TBL] [Abstract][Full Text] [Related]
2. In vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Carbapenem-resistant
Zou C; Wei J; Shan B; Chen X; Wang D; Niu S
Infect Drug Resist; 2020; 13():3563-3568. PubMed ID: 33116675
[TBL] [Abstract][Full Text] [Related]
3. Genetic diversity and in vitro activity of ceftazidime/avibactam and aztreonam/avibactam against imipenem-resistant Enterobacteriaceae isolates in Southwest China: A single-centre study.
Wei J; Zou C; Wang D; Huang A; Niu S
J Glob Antimicrob Resist; 2020 Sep; 22():448-451. PubMed ID: 32387260
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant
Kim T; Lee SC; Bae M; Sung H; Kim MN; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Chong YP
Antibiotics (Basel); 2020 Dec; 9(12):. PubMed ID: 33334045
[TBL] [Abstract][Full Text] [Related]
5.
Wang W; Huang S; Zou C; Ding Y; Wang H; Pu S; Liao Y; Du H; Wang D; Chen L; Niu S
Front Cell Infect Microbiol; 2021; 11():755763. PubMed ID: 34778107
[TBL] [Abstract][Full Text] [Related]
6. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.
Zhang P; Shi Q; Hu H; Hong B; Wu X; Du X; Akova M; Yu Y
Clin Microbiol Infect; 2020 Jan; 26(1):124.e1-124.e4. PubMed ID: 31494252
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of a Stable and Transferable
Huang J; Zhang S; Zhao Z; Chen M; Cao Y; Li B
Front Cell Infect Microbiol; 2021; 11():658070. PubMed ID: 34354959
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Evaluation of Increasing Avibactam Concentrations on Ceftazidime Activity against Ceftazidime/Avibactam-Susceptible and Resistant KPC-Producing
Palombo M; Secci B; Bovo F; Gatti M; Ambretti S; Gaibani P
Antibiotics (Basel); 2023 Dec; 12(12):. PubMed ID: 38136741
[TBL] [Abstract][Full Text] [Related]
9. Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro.
Lin Q; Zou H; Chen X; Wu M; Ma D; Yu H; Niu S; Huang S
BMC Microbiol; 2021 Feb; 21(1):60. PubMed ID: 33618662
[TBL] [Abstract][Full Text] [Related]
10.
Yang Y; Guo Y; Yin D; Zheng Y; Wu S; Zhu D; Hu F
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33139291
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of aztreonam/avibactam against isolates of Enterobacterales collected globally from ATLAS in 2019.
Rossolini GM; Stone G; Kantecki M; Arhin FF
J Glob Antimicrob Resist; 2022 Sep; 30():214-221. PubMed ID: 35760303
[TBL] [Abstract][Full Text] [Related]
12. Impact of Ceftazidime-Avibactam Treatment in the Emergence of Novel KPC Variants in the ST307-Klebsiella pneumoniae High-Risk Clone and Consequences for Their Routine Detection.
Hernández-García M; Castillo-Polo JA; Cordero DG; Pérez-Viso B; García-Castillo M; Saez de la Fuente J; Morosini MI; Cantón R; Ruiz-Garbajosa P
J Clin Microbiol; 2022 Mar; 60(3):e0224521. PubMed ID: 35107303
[TBL] [Abstract][Full Text] [Related]
13.
Huang YS; Chen PY; Chou PC; Wang JT
Microbiol Spectr; 2023 Jun; 11(3):e0056923. PubMed ID: 37154758
[TBL] [Abstract][Full Text] [Related]
14. Implementation of Chromatic Super CAZ/AVI
Bianco G; Boattini M; Comini S; Leone A; Bondi A; Zaccaria T; Cavallo R; Costa C
Eur J Clin Microbiol Infect Dis; 2022 Sep; 41(9):1165-1171. PubMed ID: 35933457
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of ceftazidime-avibactam against Gram-negative strains in Chile 2015-2021.
Torres-Castillo LC; Fandiño C; Ramos MP; Ramos-Castaneda JA; Rioseco ML; Juliet C
J Glob Antimicrob Resist; 2023 Dec; 35():143-148. PubMed ID: 37714380
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Susceptibility to Ceftazidime-Avibactam and Comparator Antimicrobial Agents of Carbapenem-Resistant Enterobacterales Isolates.
Lim TP; Ho JY; Teo JQ; Sim JH; Tan SH; Tan TT; Kwa AL
Microorganisms; 2023 Aug; 11(9):. PubMed ID: 37764002
[TBL] [Abstract][Full Text] [Related]
17. Detecting KPC-2 and NDM-1 Coexpression in Klebsiella pneumoniae Complex from Human and Animal Hosts in South America.
Vásquez-Ponce F; Dantas K; Becerra J; Melocco G; Esposito F; Cardoso B; Rodrigues L; Lima K; de Lima AV; Sellera FP; Mattos R; Trevisoli L; Vianello MA; Sincero T; Di Conza J; Vespero E; Gutkind G; Sampaio J; Lincopan N
Microbiol Spectr; 2022 Oct; 10(5):e0115922. PubMed ID: 35980188
[TBL] [Abstract][Full Text] [Related]
18. CP-CRE/non-CP-CRE Stratification And CRE Resistance Mechanism Determination Help In Better Managing CRE Bacteremia Using Ceftazidime-Avibactam And Aztreonam-Avibactam.
Zou H; Xiong SJ; Lin QX; Wu ML; Niu SQ; Huang SF
Infect Drug Resist; 2019; 12():3017-3027. PubMed ID: 31576152
[TBL] [Abstract][Full Text] [Related]
19. Reduced Ceftazidime-Avibactam Susceptibility in KPC-Producing
Cui X; Shan B; Zhang X; Qu F; Jia W; Huang B; Yu H; Tang YW; Chen L; Du H
Front Microbiol; 2020; 11():1365. PubMed ID: 32655534
[No Abstract] [Full Text] [Related]
20. A simple disk pre-diffusion test to predict in vitro aztreonam/avibactam activity against NDM-producing Klebsiella pneumoniae complex.
Lima KO; de Lima AV; Rocha DADC; Sampaio SCF; Cappellano P; Sampaio JLM
J Glob Antimicrob Resist; 2022 Mar; 28():49-52. PubMed ID: 34936924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]